Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score
Abstract: Background:
Recent findings strongly support hematopoietic stem cell transplantation (HSCT) in patients with severe presentation of LPS-responsive beige-like anchor protein (LRBA) deficiency, but long-term follow-up and survival data beyond previous patient reports or meta-reviews are scarce for those patients who do not receive a transplant.
Objective:
This international retrospective study was conducted to elucidate the longitudinal clinical course of patients with LRBA deficiency who do and do not receive a transplant.
Method:
We assessed disease burden and treatment responses with a specially developed immune deficiency and dysregulation activity score, reflecting the sum and severity of organ involvement and infections, days of hospitalization, supportive care requirements, and performance indices.
Results:
Of 76 patients with LRBA deficiency from 29 centers (median follow-up, 10 years; range, 1-52), 24 underwent HSCT from 2005 to 2019. The overall survival rate after HSCT (median follow-up, 20 months) was 70.8% (17 of 24 patients); all deaths were due to nonspecific, early, transplant-related mortality. Currently, 82.7% of patients who did not receive a transplant (43 of 52; age range, 3-69 years) are alive. Of 17 HSCT survivors, 7 are in complete remission and 5 are in good partial remission without treatment (together, 12 of 17 [70.6%]). In contrast, only 5 of 43 patients who did not receive a transplant (11.6%) are without immunosuppression. Immune deficiency and dysregulation activity scores were significantly lower in patients who survived HSCT than in those receiving conventional treatment (P 5 .005) or in patients who received abatacept or sirolimus as compared with other therapies, and in patients with residual LRBA expression. Higher disease burden, longer duration before HSCT, and lung involvement were associated with poor outcome.
Conclusion:
The lifelong disease activity, implying a need for immunosuppression and risk of malignancy, must be weighed against the risks of HSCT. (J Allergy Clin Immunol 2020;145:1452-63.)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
The journal of allergy and clinical immunology. - 145, 5 (2020) , 1452-1463, ISSN: 1097-6825
- Schlagwort
-
Primärer Immundefekt
Periphere Stammzellentransplantation
Sirolimus
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2020
- Urheber
- DOI
-
10.1016/j.jaci.2019.12.896
- URN
-
urn:nbn:de:bsz:25-freidok-1657319
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tesch, Victoria Katharina
- Peters, Anke M. J.
- Gámez, Laura
- Grimbacher, Bodo
- Seidel, Markus G.
- Universität
Entstanden
- 2020
Ähnliche Objekte (12)
Evaluation and management of deficiency of adenosine deaminase 2 : : an international consensus statement
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity
DOCK8 deficiency in six Iranian patients
Rapid flow cytometry-based test for the diagnosis of lipopolysaccharide responsive beige-like anchor (LRBA) deficiency
14 years after discovery : : clinical follow-up on 15 patients with Inducible CO-Stimulatior deficiency
Identifikation des genetischen Defekts in einer iranischen Familie mit chronischer mucocutaner Candidose
ARPC5 deficiency leads to severe early onset systemic inflammation and mortality
Late-onset antibody deficiency due to monoallelic alterations in NFKB1
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Klinische Erforschung der CTLA-4-Insuffizienz
STAT1-Mutationen in einer Kohorte von 62 Patienten mit chronischer mukokutaner Kandidose
Evaluation and management of deficiency of adenosine deaminase 2 : : an international consensus statement
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity
DOCK8 deficiency in six Iranian patients
Rapid flow cytometry-based test for the diagnosis of lipopolysaccharide responsive beige-like anchor (LRBA) deficiency
14 years after discovery : : clinical follow-up on 15 patients with Inducible CO-Stimulatior deficiency
Identifikation des genetischen Defekts in einer iranischen Familie mit chronischer mucocutaner Candidose
ARPC5 deficiency leads to severe early onset systemic inflammation and mortality
Late-onset antibody deficiency due to monoallelic alterations in NFKB1
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Klinische Erforschung der CTLA-4-Insuffizienz
STAT1-Mutationen in einer Kohorte von 62 Patienten mit chronischer mukokutaner Kandidose
Evaluation and management of deficiency of adenosine deaminase 2 : : an international consensus statement
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity
DOCK8 deficiency in six Iranian patients
Rapid flow cytometry-based test for the diagnosis of lipopolysaccharide responsive beige-like anchor (LRBA) deficiency
14 years after discovery : : clinical follow-up on 15 patients with Inducible CO-Stimulatior deficiency
Identifikation des genetischen Defekts in einer iranischen Familie mit chronischer mucocutaner Candidose
ARPC5 deficiency leads to severe early onset systemic inflammation and mortality
Late-onset antibody deficiency due to monoallelic alterations in NFKB1
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Klinische Erforschung der CTLA-4-Insuffizienz